Sir Jonathan Symonds is a Senior Advisor to IntraBio Inc. Sir Jonathan is the Chairman of GlaxoSmithKline. He has extensive life sciences, international finance, and governance experience.
Jon served as an Independent Non-Executive Director of HSBC Holdings plc from April 2014 and as Deputy Group Chairman from August 2018 until he retired from the Board in February 2020.
He was previously Chairman of HSBC Bank plc, Chief Financial Officer of Novartis AG, Partner and Managing Director of Goldman Sachs, Chief Financial Officer of AstraZeneca plc, and a Partner at KPMG.
His governance experience includes roles as Non-Executive Director and Chair of the Audit Committees of Diageo plc and QinetiQ Group plc and Non-Executive Chair of Proteus Digital Health Inc.
Jon is a Non-Executive Director of Rubius Therapectics, Inc; Non-Executive Director of Genomics England Limited, having previously served as its Chairman, and a Member of the European Round Table for Industry.